ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Quinoline compounds >8-Bromo-2,4-dichloroquinazoline

8-Bromo-2,4-dichloroquinazoline

8-Bromo-2,4-dichloroquinazoline Suppliers list
Company Name: Shanghai YuYuan Pharmaceutical Co., Ltd.  Gold
Tel: 13052276172
Email: product@yuyuanpharm.com
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: ChemFuture PharmaTech (Jiangsu) Ltd  
Tel: 5108538618
Email: suger.wang@chemfuture.com
Company Name: Carbott PharmTech Inc.  
Tel: 0535-6385396
Email: info@carbottpharm.com
Company Name: Pure Chemistry Scientific Inc.  
Tel: 001-857-928-2050 or 1-888-588-9418
Email: sales@chemreagents.com

8-Bromo-2,4-dichloroquinazoline manufacturers

8-Bromo-2,4-dichloroquinazoline Basic information
Application
Product Name:8-Bromo-2,4-dichloroquinazoline
Synonyms:2,4-DICHLORO-8-BROMOQUINAZOLINE;Quinazoline, 8-bromo-2,4-dichloro-;8-BROMO-2,4-DICHLOROQUINAZOLINE ISO 9001:2015 REACH;8-Bromo-2,4-dichloroquinazoline
CAS:331647-05-3
MF:C8H3BrCl2N2
MW:277.93
EINECS:
Product Categories:
Mol File:331647-05-3.mol
8-Bromo-2,4-dichloroquinazoline Structure
8-Bromo-2,4-dichloroquinazoline Chemical Properties
Boiling point 330.2±24.0 °C(Predicted)
density 1.851
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
pka-1.75±0.30(Predicted)
AppearanceOff-white to light yellow Solid
Safety Information
HazardClass IRRITANT
HS Code 2933599590
MSDS Information
8-Bromo-2,4-dichloroquinazoline Usage And Synthesis
Application8-Bromo-2,4-Dichloroquinazoline is a quinazoline derivative, which is mainly used as an intermediate in pharmaceutical and chemical synthesis.
Synthesis
8-bromoquinazoline-2,4(1H,3H)-dione

331646-99-2

8-BROMO-2,4-DICHLOROQUINAZOLINE

331647-05-3

8-Bromoquinazoline-2,4(1H,3H)-dione (12.1 g, 50 mmol, 1 eq.) was used as starting material, which was dissolved in phosphorous trichloride (POCl3, 130 mL), followed by the addition of N,N-dimethylformamide (DMF, 0.5 mL) as catalyst. The reaction mixture was stirred at 130 °C for 12 h. After completion of the reaction, the reaction was cooled to room temperature. The reaction mixture was concentrated by rotary evaporator. The concentrated residue was dissolved in ethyl acetate (EA, 100 mL) and quenched by slowly pouring into ice water under vigorous stirring. The organic phase was separated, washed with saturated saline, dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated again. Finally, the target product 8-bromo-2,4-dichloroquinazoline was purified by column chromatography (eluent: petroleum ether/ethyl acetate = 10:1, v/v) as a yellow solid (9.1 g, 60% yield).

References[1] Organic Letters, 2011, vol. 13, # 4, p. 676 - 679
[2] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 9, p. 941 - 946
[3] Patent: WO2015/27222, 2015, A2. Location in patent: Paragraph 0214
[4] Patent: WO2016/133935, 2016, A1. Location in patent: Paragraph 0287
8-Bromo-2,4-dichloroquinazoline Preparation Products And Raw materials
Raw materials8-bromoquinazoline-2,4(1H,3H)-dione-->N,N-Dimethylformamide-->trichlorophosphate
Preparation Products8-Bromo-2-chloroquinazoline-->4-Amino-8-bromo-2-chloroquinazoline
Tag:8-Bromo-2,4-dichloroquinazoline(331647-05-3) Related Product Information
8-Bromoquinolin-2-amine 8-Bromo-2H-isoquinolin-1-one 8-Bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole Quinoline, 8-bromo-2-(trifluoromethyl)- 8-BroMo-2-chloro-6-fluoro-quinazoline 8-bromo-2-chloroquinoxaline 8-bromo-2-methylimidazo[1,2-a]pyridine 8-Bromo-3-iodoimidazo[1,2-a]pyrazine 3-Quinolinamine,8-bromo-(9CI) 8-Bromo-3,4-dihydro-1H-[1,6]naphthyridin-2-one 8-BROMO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE HYDROCHLORIDE 8-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine 3-Bromoisatoic anhydride 2(1H)-Quinolinone, 8-broMo-3,4-dihydro- 8-bromo-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 8-Bromo-2,3-dihydroquinolin-4(1H)-one 2,4-Dichloroquinazoline 8-BROMO-2-CHLOROQUINAZOLINE